← Leaderboards
Michael A Brownlee
Yeshiva University
$5,232,505
Attributed
$6,489,142
Total exposure
10
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $841.9K · FY2005–13$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
Funding mix
By agency
NIH$6,489,142 · 10
By mechanism
R01$5,106,473 · 4
R56$898,400 · 2
P01$458,433 · 1
M01$25,836 · 3
Top collaborators
- Geoffrey C Gurtner5 shared
Most similar at Yeshiva University
Same institution · by research overlap
- Luciano Rossetti$6,255,407
- Gerard Anthony Lutty$14,318,233
- Ilan Gabriely$2,494,326
Others in their field
Top investigators on “Hyperglycemia”
- Rose A Gubitosi-Klug · Case Western Reserve University$72,785,524
- Jeffrey P Krischer · University Of South Florida$36,581,753
- Boyd E Metzger · Northwestern University$36,326,756
- Anastassios G Pittas · Tufts Medical Center$31,052,547
- George L King · Joslin Diabetes Center$27,911,701
- John M Lachin · George Washington University$21,318,885
Research focus
HyperglycemiaHypoxiaBlood VesselsResponseDiabetes MellitusReactive Oxygen SpeciesImpaired Wound HealingCoronary ArteriosclerosisGlyoxalLaboratory MouseFunctional DisorderGrowthAffectNeovascularizationDiabetic RetinopathyImpairmentCerebrovascular DisordersCellsGlycationCarbon Sulfur LyaseGenetically Modified AnimalsBone MarrowIschemiaSignal Transduction
Grant awards (24)
Progenitor Cell Dysfunction and Impaired Neovascularization in Diabetes$450,529
R01 · FY2013 · DK
Progenitor Cell Dysfunction and Impaired Neovascularization in Diabetes$469,196
R01 · FY2012 · DK
Progenitor Cell Dysfunction and Impaired Neovascularization in Diabetes$471,152
R01 · FY2011 · DK
Progenitor Cell Dysfunction and Impaired Neovascularization in Diabetes$622,398
R01 · FY2010 · DK
Progenitor Cell Dysfunction and Impaired Neovascularization in Diabetes$500,000
R56 · FY2009 · DK
Progenitor Cell Dysfunction and Impaired Vasculogenesis*$146,537
R01 · FY2008 · DK · contact PI
BENFOTHIMI I$2,279
M01 · FY2008 · RR · contact PI
NUTRIENT EXCESS AND ACCELERATED ARTERIAL AGING$274,569
P01 · FY2007 · AG · contact PI
Progenitor Cell Dysfunction and Impaired Vasculogenesis*$149,528
R01 · FY2007 · DK · contact PI
Intracellular Glycation and Diabetic Complications$41,500
R56 · FY2007 · DK · contact PI
BENFOTHIMI I$5,838
M01 · FY2007 · RR · contact PI
Intracellular Glycation and Diabetic Complications$356,900
R56 · FY2006 · DK · contact PI
NUTRIENT EXCESS AND ACCELERATED ARTERIAL AGING$183,864
P01 · FY2006 · AG · contact PI
Progenitor Cell Dysfunction and Impaired Vasculogenesis*$153,995
R01 · FY2006 · DK · contact PI
Intracellular Glycation and Diabetic Complications$129,425
R01 · FY2006 · DK · contact PI
BENFOTHIMI I$17,719
M01 · FY2006 · RR · contact PI
Intracellular Glycation and Diabetic Complications$359,344
R01 · FY2005 · DK
Progenitor Cell Dysfunction and Impaired Vasculogenesis*$156,829
R01 · FY2005 · DK
Intracellular Glycation and Diabetic Complications$359,344
R01 · FY2004 · DK
Intracellular Glycation and Diabetic Complications$354,412
R01 · FY2003 · DK
Intracellular Glycation and Diabetic Complications$355,595
R01 · FY2002 · DK
Intracellular Glycation and Diabetic Complications$356,150
R01 · FY2001 · DK
GENETIC ENGINEERING OF BETA CELLS FOR TRANSPLANTATION$470,934
R01 · FY2000 · DK
INTRACELLULAR GLYCATION AND DIABETIC COMPLICATIONS$101,105
R01 · FY2000 · DK